ALLERTIN CAPSULE

Quốc gia: Canada

Ngôn ngữ: Tiếng Anh

Nguồn: Health Canada

Thành phần hoạt chất:

LORATADINE

Sẵn có từ:

APOTEX INC

Mã ATC:

R06AX13

INN (Tên quốc tế):

LORATADINE

Liều dùng:

10MG

Dạng dược phẩm:

CAPSULE

Thành phần:

LORATADINE 10MG

Tuyến hành chính:

ORAL

Các đơn vị trong gói:

12/24

Loại thuốc theo toa:

OTC

Khu trị liệu:

SECOND GENERATION ANTIHISTAMINES

Tóm tắt sản phẩm:

Active ingredient group (AIG) number: 0120416001; AHFS:

Tình trạng ủy quyền:

APPROVED

Ngày ủy quyền:

2012-08-02

Đặc tính sản phẩm

Page 2 of 20
PRODUCT MONOGRAPH
ALLERTIN
LORATADINE CAPSULES, 10 MG
HISTAMINE H
1 RECEPTOR ANTAGONIST
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
SEPTEMBER 25, 2019
TORONTO, ONTARIO
CANADA M9L 1T9
CONTROL #: 231181
Page 3 of 20
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................
4
SUMMARY PRODUCT INFORMATION
.............................................................................................
4
INDICATIONS AND CLINICAL USE
...................................................................................................
4
CONTRAINDICATIONS
........................................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................................
4
ADVERSE REACTIONS
.........................................................................................................................
5
DRUG INTERACTIONS
.........................................................................................................................
6
DOSAGE AND ADMINISTRATION
.....................................................................................................
7
OVERDOSAGE
.......................................................................................................................................
7
ACTION AND CLINICAL
PHARMACOLOGY....................................................................................
8
STORAGE AND STABILITY
.................................................................................................................
9
SPECIAL HANDLING INSTRUCTIONS
..............................................................................................
9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................................... 9
PART II: SCIENTIFIC INFORMATION
.....................................................................